Last reviewed · How we verify
femoral dexamethasone
At a glance
| Generic name | femoral dexamethasone |
|---|---|
| Also known as | dekort |
| Sponsor | TC Erciyes University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Pericapsular Nerve Group Block Added to Intra-articular Corticosteroid Injection in the Treatment of Hip Pain
- Comparison Between Combined Biceps Femoris Short Head Block and Adductor Canal Block Versus Genicular Nerve Block (NA)
- Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks (PHASE1, PHASE2)
- The Ultrasound Guided Pericapsular Nerve Group and Anterior Quadratus Lumborum Blocks in Hip Replacement Surgeries (PHASE4)
- PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach (NA)
- Pulsed Radiofrequency Ablation and Steroid Injections for the Treatment of Meralgia Paresthetica (NA)
- Genicular and Anterior Femoral Cutaneous Nerve Blocks for Total Knee Arthroplasty (PHASE4)
- Anterior Femoral and Adductor Canal Nerve Blocks in Peds Knees (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- femoral dexamethasone CI brief — competitive landscape report
- femoral dexamethasone updates RSS · CI watch RSS
- TC Erciyes University portfolio CI